In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Hospital Equipment It's Goodbye Agilent, Hello Philips-Andover

Executive Summary

With its $1.7 billion acquisition of the Healthcare Solutions Group (HSG) of Agilent Technologies, the fourth major purchase for the company in less than two-and-a-half years, Philips Medical Systems believes it now has the muscle to compete long term with its principle competitors in the global hospital equipment market: GE Medical Systems and Siemens Medical Systems. As patient monitoring and clinical systems have become more integrated, drawing information in multiple formats from many hospital departments and remote locations, hospitals increasingly want to work with a single supplier, driving consolidation. Being the winner, or highly competitive, on a product-to-product basis, as Philips has been in its markets, is no longer enough. Thus, to maintain a level playing field with GE and Siemens, which have each been bulking up via acquisition this year--notably Siemens with Acuson and Shared Medical Systems, and GE with Critikon, plus many smaller purchases--Philips has also been expanding the size, breadth, and depth of its offerings. For Agilent, the deal puts to rest a half-year's worth of speculation about what it would do with HSG, which had experienced declining orders and revenues in the last two quarters, leading to an August 2000 restructuring.

You may also be interested in...



Pelikan Technologies Inc.

Pelikan Technologies Inc. hopes to eliminate the procedural drawbacks that deter diabetics from frequent monitoring with an integrated system that combines electronic lancing and glucose monitoring in one step.

Pelikan Technologies Inc.

Pelikan Technologies Inc. hopes to eliminate the procedural drawbacks that deter diabetics from frequent monitoring with an integrated system that combines electronic lancing and glucose monitoring in one step.

SpaceLabs Finds an Exit in Instrumentarium

Just as it did when it bought Datex-Ohmeda, the anesthesia equipment company, Instrumentarium has scooped up a US firm that built a US presence in an important technology area. This time the play is for SpaceLabs in critical care monitoring. For SpaceLabs, the acquisition ends a difficult time as it tried to remain independent in the face of a declining share price and heightened competition from some of capital equipment's largest players.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV001347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel